SA
DMRA logo
Damora Therapeutics, Inc.(DMRA)
Closing price · checked 8:21 PM ETAbout this dataData status
$23.22▼-1.08 (-4.44%)
Extended:$23.22+0.00 (+0.00%)· 8:21 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Damora Therapeutics, Inc. (DMRA)

Operating Cash Flow (Statement)

-$59.13M

TTM · Period ending: · USD

DMRA logo

DMRA Operating Cash Flow (Statement)

Latest reported-$59.13M
DMRA Cash from Operations (-$13.69M → -$59.13M)
High-resolution chart · PNG

What is operating cash flow (statement)?

Net cash provided by operating activities.

DMRA operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Damora Therapeutics, Inc. Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)Change
-6,726,000—
-18,623,000—
-36,911,000—
-42,932,000—
-52,308,000—
-38,203,000—
-19,326,000—
-13,691,000—

Frequently asked questions: DMRA operating cash flow (statement)

What is Damora Therapeutics, Inc. (DMRA)'s current operating cash flow (statement)?

Damora Therapeutics, Inc. (DMRA)'s latest reported operating cash flow (statement) (TTM) is -$59.13M as of Sep 30, 2026. Net cash provided by operating activities.

How much historical operating cash flow (statement) data is available for DMRA?

Stock Alarm Pro provides 8 dated annual fiscal periods observations for Damora Therapeutics, Inc. (DMRA)'s operating cash flow (statement), allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare DMRA's operating cash flow (statement) to peers or set an alert?

You can open DMRA's operating cash flow (statement) in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on DMRA delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.